1. Home
  2. WAY vs RYTM Comparison

WAY vs RYTM Comparison

Compare WAY & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAY
  • RYTM
  • Stock Information
  • Founded
  • WAY 1999
  • RYTM 2008
  • Country
  • WAY United States
  • RYTM United States
  • Employees
  • WAY N/A
  • RYTM N/A
  • Industry
  • WAY
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • WAY
  • RYTM Health Care
  • Exchange
  • WAY Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • WAY 6.7B
  • RYTM 6.4B
  • IPO Year
  • WAY 2024
  • RYTM 2017
  • Fundamental
  • Price
  • WAY $37.93
  • RYTM $99.50
  • Analyst Decision
  • WAY Strong Buy
  • RYTM Strong Buy
  • Analyst Count
  • WAY 13
  • RYTM 13
  • Target Price
  • WAY $44.92
  • RYTM $109.77
  • AVG Volume (30 Days)
  • WAY 4.4M
  • RYTM 634.5K
  • Earning Date
  • WAY 11-05-2025
  • RYTM 11-04-2025
  • Dividend Yield
  • WAY N/A
  • RYTM N/A
  • EPS Growth
  • WAY N/A
  • RYTM N/A
  • EPS
  • WAY 0.48
  • RYTM N/A
  • Revenue
  • WAY $1,011,303,000.00
  • RYTM $156,287,000.00
  • Revenue This Year
  • WAY $11.39
  • RYTM $46.10
  • Revenue Next Year
  • WAY $10.18
  • RYTM $60.39
  • P/E Ratio
  • WAY $78.49
  • RYTM N/A
  • Revenue Growth
  • WAY 17.14
  • RYTM 53.55
  • 52 Week Low
  • WAY $26.85
  • RYTM $45.91
  • 52 Week High
  • WAY $48.11
  • RYTM $106.52
  • Technical
  • Relative Strength Index (RSI)
  • WAY 54.07
  • RYTM 53.31
  • Support Level
  • WAY $36.11
  • RYTM $95.88
  • Resistance Level
  • WAY $39.12
  • RYTM $102.79
  • Average True Range (ATR)
  • WAY 1.03
  • RYTM 3.28
  • MACD
  • WAY 0.02
  • RYTM -0.18
  • Stochastic Oscillator
  • WAY 59.29
  • RYTM 53.99

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: